Results 31 to 40 of about 9,470 (201)

Effect of High-Dose Topical Minoxidil on Erythrocyte Quality in SKH1 Hairless Mice

Animals, 2020
SKH1 hairless mice are widely used in carcinogenesis and dermatology research due to their bare skin, as exposure to different agents is facilitated. Minoxidil is a cosmetic drug that is recognized as a mitogenic agent, and mitogens are suggested to have
Eduardo Naranjo-Vázquez, María Guadalupe Sánchez-Parada, Belinda Claudia Gómez-Meda, Ana Lourdes Zamora-Perez, Martha Patricia Gallegos-Arreola, Ana Elizabeth González-Santiago, Guillermo Moisés Zúñiga-González   +6 more
doaj   +1 more source

Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review

JEADV Clinical Practice, EarlyView.
This systematic review identifies consistent clinical patterns of alopecia areata associated with IL‐17 and IL‐23 inhibitors, most frequently involving secukinumab and ustekinumab. Disease severity varied widely, and management often required biologic discontinuation or therapeutic switching.
Isabella Kamholtz, Simonetta I. Gaumond, Joaquin J. Jimenez   +2 more
wiley   +1 more source

The efficacy of topical minoxidil 2% versus topical botanically derived inhibitors of 5 alpha reductase in treatment of female pattern hair loss by trichoscopy

Journal of the Egyptian Women’s Dermatologic Society, 2019
Background Female pattern hair loss (FPHL) is a distressing common problem. Minoxidil is the only FDA approved medical treatment for FPHL. However, the off-label botanically derived 5-alpha reductase inhibitors (5αRIs) are commonly used despite ...
Fairouz K Badran, Rania E Abd El Maksoud, Mona M Ibrahim Moawad   +2 more
doaj   +1 more source

Application of topical minoxidil in acne vulgaris treatment

Dermatologica Sinica
Background: Acne vulgaris (AV) results from increased sebum production and Cutibacterium acnes (C. acnes) overgrowth, leading to pilosebaceous unit inflammation.
Chun-Bing Chen, Yung-Chia Kuo, Sun-Min Chang, An-Chi Lin, Hsien-Chi Fan, Tung-Liang Lin, Wen-Hung Chung, Cheng-Lung Hsu   +7 more
doaj   +1 more source

Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride

Indian Dermatology Online Journal, 2015
Background: Finasteride acts by reducing dihydrotestosterone levels, thereby inhibiting miniaturization of hair follicles in patients with androgenetic alopecia (AGA).
B S Chandrashekar, T Nandhini, Vani Vasanth, Rashmi Sriram, Shreya Navale   +4 more
doaj   +1 more source

Comparative study of efficacy of excimer light therapy vs. intralesional triamcinolone vs. topical 5% minoxidil for alopecia areata: an observational study

, 2015
Introduction. Alopecia areata (AA) is a chronic inflammatory disease that involves hair follicles, and sometimes nails, caused by a T-cell mediated autoimmune mechanism.
Zo Nun Sanga
core   +1 more source

Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes [PDF]

, 2019
Minoxidil sulfate is the active metabolite required to exert the vasodilatory and hair growing effects of minoxidil. For hair growth, sulfotransferase enzymes expressed in outer root sheath of the hair follicle sulfonate minoxidil.
Sinclair, R, Kovacevic, M, Tan, Y, McCoy, J, Trüeb, RM, Situm, M, Sharma, A, Agrawal, S, Goren, A, Chen, G, Dhurat, R, Vañó-Galván, S   +11 more
core   +1 more source

Pharmacokinetics and Safety of 1 mg Oral Minoxidil Tablets in Healthy Female Volunteers: A Phase I Randomized Crossover Clinical Trial

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Topical minoxidil is a first‐line treatment for female androgenetic alopecia (FAGA); however, its twice‐daily application, potential for scalp irritation and impact on hair texture can compromise adherence. Although low‐dose oral minoxidil has emerged as a promising alternative, standardized formulations with well‐characterized ...
Dolores Ochoa Mazarro, Ignacio Galicia, Ana López‐Ballesteros   +2 more
wiley   +1 more source

Research Trends in Telogen Effluvium From 1975 to 2025: A Bibliometric Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Telogen effluvium (TE) is a common cause of diffuse hair loss. Bibliometric analyses systematically map research trends to identify influential studies and reveal knowledge gaps. Objectives To characterize research trends, influential publications, and knowledge gaps in the telogen effluvium literature through bibliometric analysis ...
Katya Peri, Eric McMullen, Megan Park, Narachai Julanon, Jeffrey Donovan, Cathryn Sibbald   +5 more
wiley   +1 more source

Risks of minoxidil toxicity for household pets

Toxicology Communications
Background Topical minoxidil is a popular over-the-counter treatment for hair loss, but it is highly toxic to pets, particularly cats. Severe and sometimes fatal outcomes have occurred, yet public awareness remains limited.
Michael M. Ong, Brittany Parsons, Shari R. Lipner   +2 more
doaj   +1 more source